BDRX
BiodexaDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Composite grade D from latest DB weights. Momentum 26.6 / Value 46.5
Posture
Defensive
Lead driver
Value
What changed
Next scheduled catalyst: earnings 2026-09-10.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
27
Value
46
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -Analysis date unavailable; returns require an exact persisted reference.
Earnings
2026-09-10
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-08 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-09-08
Investment thesis
As of 2026-09-08
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-08. Definitions
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $10.00
Why
Momentum27 · Δ7d -
Value46 · Δ7d 0.0
SentimentN/A · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Next scheduled catalyst: earnings 2026-09-10.
- • Value remains the lead driver in the composite, 7D delta 0.0.
Contradictions & invalidation
- • Mixed signals. Wait for cleaner trend confirmation.
Catalyst clock
2026-09-10
Lead driver: Value · See fundamentals
Momentum
27
25% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
46
75% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
-0.0
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade D. Momentum 26.6 / Value 46.5
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$6.41B
Beta
1.01
Shares Out
451.64K
P/E (TTM) · Derived
-179.6
P/S (TTM)
-
P/FCF (TTM) · Derived
-155.83
Rev YoY
-100.0%
EPS YoY
+99.4%
Gross Margin
-234.0%
Op Margin
-9630.1%
Net Debt
-$11.4M
Current Ratio
2.03
As of 2026-09-08 • Updated nightlySource: Internal modelMethods & Data